世界のグルコース依存性インスリン分泌性受容体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glucose Dependent Insulinotropic Receptor Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5756 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、グルコース依存性インスリン分泌性受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DA-1241、GSK-2041706、HD-0471042、HD-0471953、HOB-047、MBX-2982、その他）、用途別市場規模（2型糖尿病、肥満、慢性閉塞性肺疾患（COPD）、脂質異常症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・グルコース依存性インスリン分泌性受容体の市場動向 ・企業の競争状況、市場シェア ・グルコース依存性インスリン分泌性受容体の種類別市場規模と予測2016-2027（DA-1241、GSK-2041706、HD-0471042、HD-0471953、HOB-047、MBX-2982、その他） ・グルコース依存性インスリン分泌性受容体の用途別市場規模と予測2016-2027（2型糖尿病、肥満、慢性閉塞性肺疾患（COPD）、脂質異常症、その他） ・グルコース依存性インスリン分泌性受容体の北米市場規模2016-2027（アメリカ、カナダ） ・グルコース依存性インスリン分泌性受容体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・グルコース依存性インスリン分泌性受容体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・グルコース依存性インスリン分泌性受容体の中南米市場規模2016-2027（メキシコ、ブラジル） ・グルコース依存性インスリン分泌性受容体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen Inc、Arena Pharmaceuticals Inc、CymaBay Therapeutics Inc、Dong-A Socio Holdings Co Ltd、F. Hoffmann-La Roche Ltd、GlaxoSmithKline Plc、Hyundai Pharmaceutical Co Ltd、Kowa Co Ltd、Merck & Co Inc、Novartis AG、Taisho Pharmaceutical Holdings Co Ltd、Takeda Pharmaceutical Co Ltd、Yuhan Corp） ・結論

Market Analysis and Insights: Global Glucose Dependent Insulinotropic Receptor Market
The global Glucose Dependent Insulinotropic Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glucose Dependent Insulinotropic Receptor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glucose Dependent Insulinotropic Receptor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glucose Dependent Insulinotropic Receptor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glucose Dependent Insulinotropic Receptor market.

Global Glucose Dependent Insulinotropic Receptor Scope and Market Size
Glucose Dependent Insulinotropic Receptor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glucose Dependent Insulinotropic Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
DA-1241
GSK-2041706
HD-0471042
HD-0471953
HOB-047
MBX-2982
Others

Segment by Application
Type 2 Diabetes
Obesity
Chronic Obstructive Pulmonary Disease (COPD)
Dyslipidemia
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc
Arena Pharmaceuticals Inc
CymaBay Therapeutics Inc
Dong-A Socio Holdings Co Ltd
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
Hyundai Pharmaceutical Co Ltd
Kowa Co Ltd
Merck & Co Inc
Novartis AG
Taisho Pharmaceutical Holdings Co Ltd
Takeda Pharmaceutical Co Ltd
Yuhan Corp

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 DA-1241
1.2.3 GSK-2041706
1.2.4 HD-0471042
1.2.5 HD-0471953
1.2.6 HOB-047
1.2.7 MBX-2982
1.2.8 Others
1.3 Market by Application
1.3.1 Global Glucose Dependent Insulinotropic Receptor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Type 2 Diabetes
1.3.3 Obesity
1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
1.3.5 Dyslipidemia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glucose Dependent Insulinotropic Receptor Market Perspective (2016-2027)
2.2 Glucose Dependent Insulinotropic Receptor Growth Trends by Regions
2.2.1 Glucose Dependent Insulinotropic Receptor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glucose Dependent Insulinotropic Receptor Historic Market Share by Regions (2016-2021)
2.2.3 Glucose Dependent Insulinotropic Receptor Forecasted Market Size by Regions (2022-2027)
2.3 Glucose Dependent Insulinotropic Receptor Industry Dynamic
2.3.1 Glucose Dependent Insulinotropic Receptor Market Trends
2.3.2 Glucose Dependent Insulinotropic Receptor Market Drivers
2.3.3 Glucose Dependent Insulinotropic Receptor Market Challenges
2.3.4 Glucose Dependent Insulinotropic Receptor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glucose Dependent Insulinotropic Receptor Players by Revenue
3.1.1 Global Top Glucose Dependent Insulinotropic Receptor Players by Revenue (2016-2021)
3.1.2 Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Players (2016-2021)
3.2 Global Glucose Dependent Insulinotropic Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glucose Dependent Insulinotropic Receptor Revenue
3.4 Global Glucose Dependent Insulinotropic Receptor Market Concentration Ratio
3.4.1 Global Glucose Dependent Insulinotropic Receptor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glucose Dependent Insulinotropic Receptor Revenue in 2020
3.5 Glucose Dependent Insulinotropic Receptor Key Players Head office and Area Served
3.6 Key Players Glucose Dependent Insulinotropic Receptor Product Solution and Service
3.7 Date of Enter into Glucose Dependent Insulinotropic Receptor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glucose Dependent Insulinotropic Receptor Breakdown Data by Type
4.1 Global Glucose Dependent Insulinotropic Receptor Historic Market Size by Type (2016-2021)
4.2 Global Glucose Dependent Insulinotropic Receptor Forecasted Market Size by Type (2022-2027)

5 Glucose Dependent Insulinotropic Receptor Breakdown Data by Application
5.1 Global Glucose Dependent Insulinotropic Receptor Historic Market Size by Application (2016-2021)
5.2 Global Glucose Dependent Insulinotropic Receptor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glucose Dependent Insulinotropic Receptor Market Size (2016-2027)
6.2 North America Glucose Dependent Insulinotropic Receptor Market Size by Type
6.2.1 North America Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021)
6.2.2 North America Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027)
6.2.3 North America Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2027)
6.3 North America Glucose Dependent Insulinotropic Receptor Market Size by Application
6.3.1 North America Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021)
6.3.2 North America Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027)
6.3.3 North America Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2027)
6.4 North America Glucose Dependent Insulinotropic Receptor Market Size by Country
6.4.1 North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2016-2021)
6.4.2 North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Glucose Dependent Insulinotropic Receptor Market Size (2016-2027)
7.2 Europe Glucose Dependent Insulinotropic Receptor Market Size by Type
7.2.1 Europe Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021)
7.2.2 Europe Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027)
7.2.3 Europe Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2027)
7.3 Europe Glucose Dependent Insulinotropic Receptor Market Size by Application
7.3.1 Europe Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021)
7.3.2 Europe Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027)
7.3.3 Europe Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2027)
7.4 Europe Glucose Dependent Insulinotropic Receptor Market Size by Country
7.4.1 Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2016-2021)
7.4.2 Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size (2016-2027)
8.2 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Type
8.2.1 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2027)
8.3 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Application
8.3.1 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2027)
8.4 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Region
8.4.1 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glucose Dependent Insulinotropic Receptor Market Size (2016-2027)
9.2 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Type
9.2.1 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021)
9.2.2 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027)
9.2.3 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2027)
9.3 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Application
9.3.1 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021)
9.3.2 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027)
9.3.3 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2027)
9.4 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Country
9.4.1 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Country (2016-2021)
9.4.2 Latin America Glucose Dependent Insulinotropic Receptor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size (2016-2027)
10.2 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type
10.2.1 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2027)
10.3 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application
10.3.1 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2027)
10.4 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country
10.4.1 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Introduction
11.1.4 Amgen Inc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.1.5 Amgen Inc Recent Development
11.2 Arena Pharmaceuticals Inc
11.2.1 Arena Pharmaceuticals Inc Company Details
11.2.2 Arena Pharmaceuticals Inc Business Overview
11.2.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Introduction
11.2.4 Arena Pharmaceuticals Inc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.2.5 Arena Pharmaceuticals Inc Recent Development
11.3 CymaBay Therapeutics Inc
11.3.1 CymaBay Therapeutics Inc Company Details
11.3.2 CymaBay Therapeutics Inc Business Overview
11.3.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Introduction
11.3.4 CymaBay Therapeutics Inc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.3.5 CymaBay Therapeutics Inc Recent Development
11.4 Dong-A Socio Holdings Co Ltd
11.4.1 Dong-A Socio Holdings Co Ltd Company Details
11.4.2 Dong-A Socio Holdings Co Ltd Business Overview
11.4.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Introduction
11.4.4 Dong-A Socio Holdings Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.4.5 Dong-A Socio Holdings Co Ltd Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Company Details
11.6.2 GlaxoSmithKline Plc Business Overview
11.6.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Introduction
11.6.4 GlaxoSmithKline Plc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.6.5 GlaxoSmithKline Plc Recent Development
11.7 Hyundai Pharmaceutical Co Ltd
11.7.1 Hyundai Pharmaceutical Co Ltd Company Details
11.7.2 Hyundai Pharmaceutical Co Ltd Business Overview
11.7.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Introduction
11.7.4 Hyundai Pharmaceutical Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.7.5 Hyundai Pharmaceutical Co Ltd Recent Development
11.8 Kowa Co Ltd
11.8.1 Kowa Co Ltd Company Details
11.8.2 Kowa Co Ltd Business Overview
11.8.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Introduction
11.8.4 Kowa Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.8.5 Kowa Co Ltd Recent Development
11.9 Merck & Co Inc
11.9.1 Merck & Co Inc Company Details
11.9.2 Merck & Co Inc Business Overview
11.9.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Introduction
11.9.4 Merck & Co Inc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.9.5 Merck & Co Inc Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Glucose Dependent Insulinotropic Receptor Introduction
11.10.4 Novartis AG Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.10.5 Novartis AG Recent Development
11.11 Taisho Pharmaceutical Holdings Co Ltd
11.11.1 Taisho Pharmaceutical Holdings Co Ltd Company Details
11.11.2 Taisho Pharmaceutical Holdings Co Ltd Business Overview
11.11.3 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Introduction
11.11.4 Taisho Pharmaceutical Holdings Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.11.5 Taisho Pharmaceutical Holdings Co Ltd Recent Development
11.12 Takeda Pharmaceutical Co Ltd
11.12.1 Takeda Pharmaceutical Co Ltd Company Details
11.12.2 Takeda Pharmaceutical Co Ltd Business Overview
11.12.3 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Introduction
11.12.4 Takeda Pharmaceutical Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.12.5 Takeda Pharmaceutical Co Ltd Recent Development
11.13 Yuhan Corp
11.13.1 Yuhan Corp Company Details
11.13.2 Yuhan Corp Business Overview
11.13.3 Yuhan Corp Glucose Dependent Insulinotropic Receptor Introduction
11.13.4 Yuhan Corp Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
11.13.5 Yuhan Corp Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of DA-1241
Table 3. Key Players of GSK-2041706
Table 4. Key Players of HD-0471042
Table 5. Key Players of HD-0471953
Table 6. Key Players of HOB-047
Table 7. Key Players of MBX-2982
Table 8. Key Players of Others
Table 9. Global Glucose Dependent Insulinotropic Receptor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Glucose Dependent Insulinotropic Receptor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Glucose Dependent Insulinotropic Receptor Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Glucose Dependent Insulinotropic Receptor Market Share by Regions (2016-2021)
Table 13. Global Glucose Dependent Insulinotropic Receptor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Glucose Dependent Insulinotropic Receptor Market Share by Regions (2022-2027)
Table 15. Glucose Dependent Insulinotropic Receptor Market Trends
Table 16. Glucose Dependent Insulinotropic Receptor Market Drivers
Table 17. Glucose Dependent Insulinotropic Receptor Market Challenges
Table 18. Glucose Dependent Insulinotropic Receptor Market Restraints
Table 19. Global Glucose Dependent Insulinotropic Receptor Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Glucose Dependent Insulinotropic Receptor Market Share by Players (2016-2021)
Table 21. Global Top Glucose Dependent Insulinotropic Receptor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucose Dependent Insulinotropic Receptor as of 2020)
Table 22. Ranking of Global Top Glucose Dependent Insulinotropic Receptor Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Glucose Dependent Insulinotropic Receptor Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Glucose Dependent Insulinotropic Receptor Product Solution and Service
Table 26. Date of Enter into Glucose Dependent Insulinotropic Receptor Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type (2016-2021)
Table 30. Global Glucose Dependent Insulinotropic Receptor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Glucose Dependent Insulinotropic Receptor Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application (2016-2021)
Table 34. Global Glucose Dependent Insulinotropic Receptor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Glucose Dependent Insulinotropic Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Glucose Dependent Insulinotropic Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 66. Amgen Inc Company Details
Table 67. Amgen Inc Business Overview
Table 68. Amgen Inc Glucose Dependent Insulinotropic Receptor Product
Table 69. Amgen Inc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 70. Amgen Inc Recent Development
Table 71. Arena Pharmaceuticals Inc Company Details
Table 72. Arena Pharmaceuticals Inc Business Overview
Table 73. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product
Table 74. Arena Pharmaceuticals Inc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 75. Arena Pharmaceuticals Inc Recent Development
Table 76. CymaBay Therapeutics Inc Company Details
Table 77. CymaBay Therapeutics Inc Business Overview
Table 78. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product
Table 79. CymaBay Therapeutics Inc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 80. CymaBay Therapeutics Inc Recent Development
Table 81. Dong-A Socio Holdings Co Ltd Company Details
Table 82. Dong-A Socio Holdings Co Ltd Business Overview
Table 83. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product
Table 84. Dong-A Socio Holdings Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 85. Dong-A Socio Holdings Co Ltd Recent Development
Table 86. F. Hoffmann-La Roche Ltd Company Details
Table 87. F. Hoffmann-La Roche Ltd Business Overview
Table 88. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product
Table 89. F. Hoffmann-La Roche Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 90. F. Hoffmann-La Roche Ltd Recent Development
Table 91. GlaxoSmithKline Plc Company Details
Table 92. GlaxoSmithKline Plc Business Overview
Table 93. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product
Table 94. GlaxoSmithKline Plc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 95. GlaxoSmithKline Plc Recent Development
Table 96. Hyundai Pharmaceutical Co Ltd Company Details
Table 97. Hyundai Pharmaceutical Co Ltd Business Overview
Table 98. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product
Table 99. Hyundai Pharmaceutical Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 100. Hyundai Pharmaceutical Co Ltd Recent Development
Table 101. Kowa Co Ltd Company Details
Table 102. Kowa Co Ltd Business Overview
Table 103. Kowa Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 104. Kowa Co Ltd Recent Development
Table 105. Merck & Co Inc Company Details
Table 106. Merck & Co Inc Business Overview
Table 107. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product
Table 108. Merck & Co Inc Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 109. Merck & Co Inc Recent Development
Table 110. Novartis AG Company Details
Table 111. Novartis AG Business Overview
Table 112. Novartis AG Glucose Dependent Insulinotropic Receptor Product
Table 113. Novartis AG Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 114. Novartis AG Recent Development
Table 115. Taisho Pharmaceutical Holdings Co Ltd Company Details
Table 116. Taisho Pharmaceutical Holdings Co Ltd Business Overview
Table 117. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product
Table 118. Taisho Pharmaceutical Holdings Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 119. Taisho Pharmaceutical Holdings Co Ltd Recent Development
Table 120. Takeda Pharmaceutical Co Ltd Company Details
Table 121. Takeda Pharmaceutical Co Ltd Business Overview
Table 122. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product
Table 123. Takeda Pharmaceutical Co Ltd Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 124. Takeda Pharmaceutical Co Ltd Recent Development
Table 125. Yuhan Corp Company Details
Table 126. Yuhan Corp Business Overview
Table 127. Yuhan Corp Glucose Dependent Insulinotropic Receptor Product
Table 128. Yuhan Corp Revenue in Glucose Dependent Insulinotropic Receptor Business (2016-2021) & (US$ Million)
Table 129. Yuhan Corp Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glucose Dependent Insulinotropic Receptor Market Share by Type: 2020 VS 2027
Figure 2. DA-1241 Features
Figure 3. GSK-2041706 Features
Figure 4. HD-0471042 Features
Figure 5. HD-0471953 Features
Figure 6. HOB-047 Features
Figure 7. MBX-2982 Features
Figure 8. Others Features
Figure 9. Global Glucose Dependent Insulinotropic Receptor Market Share by Application: 2020 VS 2027
Figure 10. Type 2 Diabetes Case Studies
Figure 11. Obesity Case Studies
Figure 12. Chronic Obstructive Pulmonary Disease (COPD) Case Studies
Figure 13. Dyslipidemia Case Studies
Figure 14. Others Case Studies
Figure 15. Glucose Dependent Insulinotropic Receptor Report Years Considered
Figure 16. Global Glucose Dependent Insulinotropic Receptor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Glucose Dependent Insulinotropic Receptor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Glucose Dependent Insulinotropic Receptor Market Share by Regions: 2020 VS 2027
Figure 19. Global Glucose Dependent Insulinotropic Receptor Market Share by Regions (2022-2027)
Figure 20. Global Glucose Dependent Insulinotropic Receptor Market Share by Players in 2020
Figure 21. Global Top Glucose Dependent Insulinotropic Receptor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucose Dependent Insulinotropic Receptor as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Glucose Dependent Insulinotropic Receptor Revenue in 2020
Figure 23. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type (2016-2021)
Figure 24. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type (2022-2027)
Figure 25. North America Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Glucose Dependent Insulinotropic Receptor Market Share by Type (2016-2027)
Figure 27. North America Glucose Dependent Insulinotropic Receptor Market Share by Application (2016-2027)
Figure 28. North America Glucose Dependent Insulinotropic Receptor Market Share by Country (2016-2027)
Figure 29. United States Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Glucose Dependent Insulinotropic Receptor Market Share by Type (2016-2027)
Figure 33. Europe Glucose Dependent Insulinotropic Receptor Market Share by Application (2016-2027)
Figure 34. Europe Glucose Dependent Insulinotropic Receptor Market Share by Country (2016-2027)
Figure 35. Germany Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Share by Region (2016-2027)
Figure 45. China Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Glucose Dependent Insulinotropic Receptor Market Share by Type (2016-2027)
Figure 53. Latin America Glucose Dependent Insulinotropic Receptor Market Share by Application (2016-2027)
Figure 54. Latin America Glucose Dependent Insulinotropic Receptor Market Share by Country (2016-2027)
Figure 55. Mexico Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Country (2016-2027)
Figure 61. Turkey Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Glucose Dependent Insulinotropic Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Amgen Inc Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 65. Arena Pharmaceuticals Inc Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 66. CymaBay Therapeutics Inc Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 67. Dong-A Socio Holdings Co Ltd Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 68. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 69. GlaxoSmithKline Plc Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 70. Hyundai Pharmaceutical Co Ltd Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 71. Kowa Co Ltd Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 72. Merck & Co Inc Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 73. Novartis AG Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 74. Taisho Pharmaceutical Holdings Co Ltd Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 75. Takeda Pharmaceutical Co Ltd Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 76. Yuhan Corp Revenue Growth Rate in Glucose Dependent Insulinotropic Receptor Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---